scholarly journals Surgical Strategy for Mitral Valve Infective Endocarditis with Concomitant Cerebral Hemorrhage and Disseminated Intravascular Coagulation Syndrome : Decompressive Craniotomy before Open-Heart Surgery

2020 ◽  
Vol 49 (4) ◽  
pp. 196-199
Author(s):  
Hikaru Uchiyama ◽  
Kojiro Furukawa ◽  
Takuya Nishijima ◽  
Yuichiro Hirata ◽  
Tatsushi Onzuka ◽  
...  
2014 ◽  
Vol 2014 ◽  
pp. 1-4
Author(s):  
Chikahiko Koeda ◽  
Atsushi Tashiro ◽  
Tomohiro Takahashi ◽  
Masanobu Niiyama ◽  
Ryohei Sakamoto ◽  
...  

A 59-year-old woman visited a local hospital for fever and was diagnosed as having infective endocarditis (IE) on the basis of blood cultures and transthoracic echocardiography. Based on clinical episodes of subarachnoid hemorrhage after admission, it was judged that she was not a good candidate for urgent open heart surgery, and it was decided to treat her with conservative medical therapy for the acute phase. We explored the optimum timing for surgery by employing gadolinium (Gd) contrast medium-enhanced magnetic resonance imaging (MRI) T2* weighted image (black dots) due to her high risk of perioperative cerebral hemorrhage. After the disappearance of the contrast media enhancement effect around the black dots, open heart surgery was performed successfully on the 103rd hospitalization day. The patient was discharged 22 days after the surgery with no clinical complications. This case suggests that disappearance of the contrast media enhancement effect around the black dots may be a useful marker for optimal timing of surgery to minimize the risk of perioperative cerebral hemorrhage in patients with IE.Learning Objective. The MRI T2* weighted images including those with Gd contrast medium enhancement effect may be useful for evaluating the risk of perioperative intracranial hemorrhage in IE.


1979 ◽  
Vol 10 (4) ◽  
pp. 643-648
Author(s):  
Kunihisa HIRATA ◽  
Toshiyuki TOKUYASU ◽  
Setsuo NISHIMURA ◽  
Shuichiro NUKI ◽  
Takashi KASAHARA ◽  
...  

2015 ◽  
Vol 18 (5) ◽  
pp. 198
Author(s):  
Xu Yong ◽  
Zheng Weiliang ◽  
Chen Yili ◽  
Zhao Lili

The risks of neurological deteriorations during open heart surgery under heparinization in patients with infective endocarditis complicated by intracranial hemorrhage remain unknown. The optimal timing for heart surgery is still a point of conflict. We report a case in which a young man who had suffered from infective endocarditis complicated with intracranial hemorrhage successfully received mitral valve replacement on day 9 after the onset of intracranial hemorrhage.


1979 ◽  
Vol 10 (2) ◽  
pp. 205-209
Author(s):  
Kunihisa HIRATA ◽  
Koji YOSHIDA ◽  
Toshiyuki TOKUYASU ◽  
Setsuo NISHIMURA ◽  
Shuichiro NUKI ◽  
...  

Heart ◽  
1973 ◽  
Vol 35 (1) ◽  
pp. 103-106 ◽  
Author(s):  
S J Wood ◽  
J Thomas ◽  
M V Braimbridge

2013 ◽  
Vol 2013 (nov14 1) ◽  
pp. bcr2013010103-bcr2013010103 ◽  
Author(s):  
K. Kongwattanakul ◽  
S. Tribuddharat ◽  
S. Prathanee ◽  
O. Pachirat

2019 ◽  
Vol 3 (3) ◽  
Author(s):  
Masahiko Asami ◽  
Thomas Pilgrim ◽  
Stephan Windecker ◽  
Fabien Praz

Abstract Background Concomitant structural degeneration of surgical mitral bioprostheses and paravalvular leak (PVL) is rare but potentially fatal. Data pertaining to simultaneous transcatheter mitral valve implantation (TMVI) and percutaneous PVL closure are limited, and the optimal treatment strategy remains undetermined. We report a case of simultaneous TMVI and double percutaneous PVL closure in a patient with a degenerated bioprosthetic mitral valve and associated medial and lateral PVLs. Case summary A 75-year-old woman who underwent combined aortic (Edwards Perimount Magna 19 mm) and mitral (Edwards Perimount Magna 25 mm) surgical valve replacement 6 years ago was referred for treatment of new-onset orthopnoea and severely reduced exercise capacity. Transoesophageal echocardiography revealed severe mitral stenosis and concomitant moderate to severe mitral regurgitation, originating from two PVLs located medial and lateral from the surgical bioprosthesis. Due to high surgical risk, we performed successful transseptal mitral valve-in-valve (ViV) implantation combined with the closure of two PVLs during the same procedure. Discussion Although surgery should be considered as a first-line treatment in this setting, most patients have extremely high or prohibitive surgical risk inherent to repeat open heart surgery. Mitral ViV implantation appears a reasonable treatment option for patients with failed mitral bioprostheses. Furthermore, a recent study of percutaneous PVL closure showed no significant difference in long-term all-cause mortality compared with redo open-heart surgery. Simultaneous TMVI and percutaneous PVL closure appears feasible in selected high-risk patients.


2003 ◽  
Vol 25 (2) ◽  
pp. 131-133 ◽  
Author(s):  
K. Ghosh ◽  
M. Madkaikar ◽  
F. Jijina ◽  
S. Gandhi ◽  
S. Shetty ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document